{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:26:17Z","timestamp":1769271977449,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Study on the mechanism of DPMAS in treating acute liver failure in children by clearing inflammatory mediators","award":["No. iGandanF1082022RGG015"],"award-info":[{"award-number":["No. iGandanF1082022RGG015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09746-6","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:26:03Z","timestamp":1769156763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of key genes in IVIG-unresponsive Kawasaki disease and their immune correlation based on bioinformatics analysis"],"prefix":"10.1007","volume":"74","author":[{"given":"Zheng-Han","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"3","key":"9746_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271\u20136. https:\/\/doi.org\/10.1542\/peds.54.3.271.","journal-title":"Pediatrics"},{"key":"9746_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110600","volume":"122","author":"Y Duan","year":"2023","unstructured":"Duan Y, Li H, Luo D, Jiang J, Liu B, Li G. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023;122:110600. https:\/\/doi.org\/10.1016\/j.intimp.2023.110600.","journal-title":"Int Immunopharmacol"},{"key":"9746_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000484","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017. https:\/\/doi.org\/10.1161\/cir.0000000000000484.","journal-title":"Circulation"},{"issue":"23","key":"9746_CR4","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y, et al. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation. 2024;150(23):e481\u2013500. https:\/\/doi.org\/10.1161\/CIR.0000000000001295.","journal-title":"Circulation"},{"issue":"4","key":"9746_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/art.42041","volume":"74","author":"M Gorelik","year":"2022","unstructured":"Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, et al. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of Kawasaki disease. Arthritis Rheum. 2022;74(4):586\u201396. https:\/\/doi.org\/10.1002\/art.42041.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9746_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3345\/cep.2021.01459","volume":"65","author":"SH Kim","year":"2022","unstructured":"Kim SH. Diagnosis of coronary artery abnormalities in Kawasaki disease: recent guidelines and z score systems. Clin Exp Pediatr. 2022;65(9):430\u20138. https:\/\/doi.org\/10.3345\/cep.2021.01459.","journal-title":"Clin Exp Pediatr"},{"issue":"8","key":"9746_CR7","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/CIRCRESAHA.124.325079","volume":"136","author":"PK Jena","year":"2025","unstructured":"Jena PK, Wakita D, Gomez AC, Carvalho TT, Atici AE, Aubuchon E, et al. Intestinal microbiota contributes to the development of cardiovascular inflammation and vasculitis in mice. Circ Res. 2025;136(8):e53\u201372. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325079.","journal-title":"Circ Res"},{"issue":"2","key":"9746_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.scib.2023.01.019","volume":"68","author":"B Xu","year":"2023","unstructured":"Xu B, Zhang Q, Du J, Shiraishi I, Jin H. Prediction of intravenous immunoglobulin-resistant Kawasaki disease: a research hotspot. Sci Bull (Beijing). 2023;68(2):121\u20134. https:\/\/doi.org\/10.1016\/j.scib.2023.01.019.","journal-title":"Sci Bull (Beijing)"},{"key":"9746_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2020.08.008","volume":"54","author":"RL Zhang","year":"2020","unstructured":"Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Curr Opin Pharmacol. 2020;54:72\u201381. https:\/\/doi.org\/10.1016\/j.coph.2020.08.008.","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"9746_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S2352-4642(21)00270-4","volume":"5","author":"JC Burns","year":"2021","unstructured":"Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021;5(12):852\u201361. https:\/\/doi.org\/10.1016\/S2352-4642(21)00270-4.","journal-title":"Lancet Child Adolesc Health"},{"key":"9746_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107037","author":"G Li","year":"2020","unstructured":"Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, et al. Value of C-reactive protein\/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China. Int Immunopharmacol. 2020. https:\/\/doi.org\/10.1016\/j.intimp.2020.107037.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"9746_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-01889-w","volume":"51","author":"S Wang","year":"2025","unstructured":"Wang S, Sun N, Liu P, Qian W, Xu Q, Yang D, et al. Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts. Ital J Pediatr. 2025;51(1):55. https:\/\/doi.org\/10.1186\/s13052-025-01889-w.","journal-title":"Ital J Pediatr"},{"issue":"6","key":"9746_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12519-020-00348-2","volume":"16","author":"S Wu","year":"2020","unstructured":"Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children. World J Pediatr. 2020;16(6):607\u201313. https:\/\/doi.org\/10.1007\/s12519-020-00348-2.","journal-title":"World J Pediatr"},{"issue":"1","key":"9746_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40272-017-0269-6","volume":"20","author":"LK Phuong","year":"2018","unstructured":"Phuong LK, Curtis N, Gowdie P, Akikusa J, Burgner D. Treatment options for resistant Kawasaki disease. Paediatr Drugs. 2018;20(1):59\u201380. https:\/\/doi.org\/10.1007\/s40272-017-0269-6.","journal-title":"Paediatr Drugs"},{"issue":"10","key":"9746_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/archdischild-2023-325639","volume":"108","author":"K Miyata","year":"2023","unstructured":"Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, et al. In\ufb02iximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis. Arch Dis Child. 2023;108(10):833\u20138. https:\/\/doi.org\/10.1136\/archdischild-2023-325639.","journal-title":"Arch Dis Child"},{"key":"9746_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115880","author":"T Matsuoka","year":"2024","unstructured":"Matsuoka T, Yashiro M. Bioinformatics analysis and validation of potential markers associated with prediction and prognosis of gastric cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25115880.","journal-title":"Int J Mol Sci"},{"key":"9746_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879657","author":"C Song","year":"2022","unstructured":"Song C, Qiao Z, Chen L, Ge J, Zhang R, Yuan S, et al. Identification of key genes as early warning signals of acute myocardial infarction based on weighted gene correlation network analysis and dynamic network biomarker algorithm. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.879657.","journal-title":"Front Immunol"},{"key":"9746_CR18","doi-asserted-by":"publisher","unstructured":"Gao S, Ma W, Lin X, Huang S, Yu M. Identification of key genes and underlying mechanisms in acute Kawasaki disease based on bioinformatics analysis. Med Sci Monit. 2021;27. https:\/\/doi.org\/10.12659\/msm.930547.","DOI":"10.12659\/msm.930547"},{"issue":"12","key":"9746_CR19","first-page":"1198","volume":"25","author":"YJ Huang","year":"2023","unstructured":"Huang YJ, Li SL, Tian Y, Yang XD, Wang H. Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023). Chin J Contemp Pediatr. 2023;25(12):1198\u2013210.","journal-title":"Chin J Contemp Pediatr"},{"key":"9746_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85394-4","author":"EJ Cheon","year":"2025","unstructured":"Cheon EJ, Kim GB, Park S. Predictive modeling of consecutive intravenous immunoglobulin treatment resistance in Kawasaki disease: a nationwide study. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-85394-4.","journal-title":"Sci Rep"},{"key":"9746_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66135-5","author":"L Deng","year":"2024","unstructured":"Deng L, Wang T, Duan Y, Liu B, Jiang J, Liu D, et al. Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-66135-5.","journal-title":"Sci Rep"},{"key":"9746_CR22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060423","author":"MBF Son","year":"2023","unstructured":"Son MBF, Gauvreau K, Newburger JW. Failure of risk prediction modeling for IVIG resistance in Kawasaki disease. Pediatrics. 2023. https:\/\/doi.org\/10.1542\/peds.2022-060423.","journal-title":"Pediatrics"},{"key":"9746_CR23","doi-asserted-by":"publisher","unstructured":"Tang B, Lo HH, Lei C, U KI, Hsiao WW, Guo X, et al. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: an overview of epidemiology, pathogenesis, diagnosis and Pharmacological treatment of Kawasaki disease. Phytomedicine. 2020;70:153208. https:\/\/doi.org\/10.1016\/j.phymed.2020.153208.","DOI":"10.1016\/j.phymed.2020.153208"},{"key":"9746_CR24","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.2147\/jir.S378080","volume":"15","author":"Z Lu","year":"2022","unstructured":"Lu Z, Zheng Z, Xu Y, Wang C, Lin Y, Lin K, et al. The associated of the risk of IVIG resistance in Kawasaki disease with ZNF112 gene and ZNF180 gene in a Southern Chinese population. J Inflamm Res. 2022;15:5053\u201362. https:\/\/doi.org\/10.2147\/jir.S378080.","journal-title":"J Inflamm Res"},{"issue":"7","key":"9746_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391\u2013405. https:\/\/doi.org\/10.1038\/s41584-020-0426-0.","journal-title":"Nat Rev Rheumatol"},{"key":"9746_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1566985","author":"X-Y Han","year":"2025","unstructured":"Han X-Y, Qi H-R. Pyroptosis in Kawasaki disease: from mechanisms to targeted interventions. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1566985.","journal-title":"Front Immunol"},{"issue":"6","key":"9746_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41390-019-0710-3","volume":"87","author":"Y Yoshida","year":"2020","unstructured":"Yoshida Y, Takeshita S, Kawamura Y, Kanai T, Tsujita Y, Nonoyama S. Enhanced formation of neutrophil extracellular traps in Kawasaki disease. Pediatr Res. 2020;87(6):998\u20131004. https:\/\/doi.org\/10.1038\/s41390-019-0710-3.","journal-title":"Pediatr Res"},{"issue":"1","key":"9746_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1756-185x.13207","volume":"21","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis. 2017;21(1):31\u20135. https:\/\/doi.org\/10.1111\/1756-185x.13207.","journal-title":"Int J Rheum Dis"},{"key":"9746_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.697632","volume":"9","author":"L Chang","year":"2021","unstructured":"Chang L, Yang HW, Lin TY, Yang KD. Perspective of immunopathogenesis and immunotherapies for Kawasaki Disease. Front Pediatr. 2021;9:697632. https:\/\/doi.org\/10.3389\/fped.2021.697632.","journal-title":"Front Pediatr"},{"key":"9746_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152261","author":"Y Xie","year":"2022","unstructured":"Xie Y, Han B. Exploring the relationship between pyroptosis, infiltrating immune cells and Kawasaki disease with resistance to intravenous immunoglobulin (IVIG) via bioinformatic analysis. Immunobiology. 2022. https:\/\/doi.org\/10.1016\/j.imbio.2022.152261.","journal-title":"Immunobiology"},{"issue":"1","key":"9746_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028702","volume":"30","author":"Y Pan","year":"2020","unstructured":"Pan Y, Fan Q. Identification of potential core genes in Immunoglobulin-Resistant Kawasaki disease using bioinformatics analysis. Crit Rev Eukaryot Gene Expr. 2020;30(1):85\u201391. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2020028702.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"9746_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1182512","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Cao Y, Li Y, Yuan M, Xu J, Li J. Identification of key signaling pathways and hub genes related to immune infiltration in Kawasaki disease with resistance to intravenous immunoglobulin based on weighted gene co-expression network analysis. Front Mol Biosci. 2023;10:1182512. https:\/\/doi.org\/10.3389\/fmolb.2023.1182512.","journal-title":"Front Mol Biosci"},{"key":"9746_CR33","doi-asserted-by":"publisher","unstructured":"Bayry J, Wang Y, Li Z, Hu G, Hao S, Deng X, et al. Unique molecular patterns uncovered in Kawasaki disease patients with elevated serum gamma Glutamyl transferase levels: implications for intravenous Immunoglobulin responsiveness. PLoS ONE. 2016;11(12). https:\/\/doi.org\/10.1371\/journal.pone.0167434.","DOI":"10.1371\/journal.pone.0167434"},{"key":"9746_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/life15071012","author":"A Agrafiotou","year":"2025","unstructured":"Agrafiotou A, Sapountzi E, Margoni A, Fotis L. Immunophenotype of Kawasaki disease: insights into pathogenesis and treatment response. Life. 2025. https:\/\/doi.org\/10.3390\/life15071012.","journal-title":"Life"},{"issue":"5","key":"9746_CR35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.12669\/pjms.38.5.5408","volume":"38","author":"H Zhang","year":"2022","unstructured":"Zhang H, Song HB, Wang DX, Deng HY, Sun WL. Correlation between the level of inflammatory cytokines and prognosis in children with IVIG-sensitive Kawasaki disease and IVIG-resistant Kawasaki disease. Pak J Med Sci. 2022;38(5):1165\u20139. https:\/\/doi.org\/10.12669\/pjms.38.5.5408.","journal-title":"Pak J Med Sci"},{"key":"9746_CR36","doi-asserted-by":"publisher","first-page":"10999","DOI":"10.2147\/JIR.S490095","volume":"17","author":"S Li","year":"2024","unstructured":"Li S, Zhou Y, Wen Y, Wu Y, Liu F, Ding Y. Role of pyroptosis in IVIG-Resistant Kawasaki disease and the establishment of a new predictive model. J Inflamm Res. 2024;17:10999\u20131008. https:\/\/doi.org\/10.2147\/JIR.S490095.","journal-title":"J Inflamm Res"},{"issue":"8","key":"9746_CR37","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1093\/rheumatology\/keaf188","volume":"64","author":"M Yang","year":"2025","unstructured":"Yang M, Zhang M, Wang H, Li X. Risk factors for non-response to initial IVIG plus methylprednisolone therapy in children with Kawasaki disease. Rheumatology (Oxford). 2025;64(8):4607\u201313. https:\/\/doi.org\/10.1093\/rheumatology\/keaf188.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"9746_CR38","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/all.14281","volume":"75","author":"T Inoue","year":"2020","unstructured":"Inoue T, Miyashita M, Murakami S, Igarashi A, Motomura K, Abe J, et al. IL-1beta and IL-17A are involved in IVIG resistance through activation of C\/EBPbeta and delta in a coronary artery model of Kawasaki disease. Allergy. 2020;75(8):2102\u20135. https:\/\/doi.org\/10.1111\/all.14281.","journal-title":"Allergy"},{"issue":"2","key":"9746_CR39","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9593","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li C, Niu L, Fu M, Tian J, An X. Difference in serum miRNA expression between immunoglobulin-sensitive and -insensitive incomplete Kawasaki disease patients. Exp Ther Med. 2021;21(2):162. https:\/\/doi.org\/10.3892\/etm.2020.9593.","journal-title":"Exp Ther Med"},{"issue":"6","key":"9746_CR40","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s10875-022-01301-w","volume":"42","author":"C Kessel","year":"2022","unstructured":"Kessel C, Kone-Paut I, Tellier S, Belot A, Masjosthusmann K, Wittkowski H, et al. An Immunological Axis Involving Interleukin 1\u03b2 and Leucine-Rich-\u03b12-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial. J Clin Immunol. 2022;42(6):1330\u201341. https:\/\/doi.org\/10.1007\/s10875-022-01301-w.","journal-title":"J Clin Immunol"},{"key":"9746_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155828","volume":"153","author":"K Matsushima","year":"2022","unstructured":"Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine. Cytokine. 2022;153:155828. https:\/\/doi.org\/10.1016\/j.cyto.2022.155828.","journal-title":"Cytokine"},{"issue":"10","key":"9746_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00431-007-0642-5","volume":"167","author":"M Miura","year":"2008","unstructured":"Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous Immunoglobulin. Eur J Pediatr. 2008;167(10):1119\u201323. https:\/\/doi.org\/10.1007\/s00431-007-0642-5.","journal-title":"Eur J Pediatr"},{"key":"9746_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2024.2384674","author":"JW Kwak","year":"2024","unstructured":"Kwak JW, Nguyen HQ, Camai A, Huffman GM, Mekvanich S, Kenney NN, et al. <Emphasis Type=\"Italic\">CXCR1<\/Emphasis>\/2 antagonism inhibits neutrophil function and not recruitment in cancer. Oncoimmunology. 2024. https:\/\/doi.org\/10.1080\/2162402x.2024.2384674.","journal-title":"Oncoimmunology"},{"key":"9746_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108257","author":"K Dhayni","year":"2022","unstructured":"Dhayni K, Zibara K, Issa H, Kamel S, Bennis Y. Targeting <Emphasis Type=\"Italic\">CXCR1<\/Emphasis> and <Emphasis Type=\"Italic\">CXCR2<\/Emphasis> receptors in cardiovascular diseases. Pharmacol Ther. 2022. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108257.","journal-title":"Pharmacol Ther"},{"key":"9746_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110052","author":"K Chen","year":"2023","unstructured":"Chen K, Gong W, Huang J, Yoshimura T, Ming Wang J. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor <Emphasis Type=\"Italic\">FPR2<\/Emphasis>. Int Immunopharmacol. 2023. https:\/\/doi.org\/10.1016\/j.intimp.2023.110052.","journal-title":"Int Immunopharmacol"},{"key":"9746_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1666240","volume":"2022","author":"T Wang","year":"2022","unstructured":"Wang T, Liu G, Guo X, Ji W, Xu Y. Single-cell analysis reveals the role of the neuropeptide receptor FPR2 in monocytes in Kawasaki disease: a bioinformatic study. Dis Markers. 2022;2022:1\u201315. https:\/\/doi.org\/10.1155\/2022\/1666240.","journal-title":"Dis Markers"},{"issue":"4","key":"9746_CR47","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/atvbaha.123.320188","volume":"44","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yang M, Zhang M, Wang H, Zheng Y, Sun R, et al. Single-cell transcriptome reveals potential mechanisms for coronary artery lesions in Kawasaki disease. Arterioscler Thromb Vasc Biol. 2024;44(4):866\u201382. https:\/\/doi.org\/10.1161\/atvbaha.123.320188.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9746_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12061010","author":"J Wang","year":"2022","unstructured":"Wang J, Xiao Q, Wang L, Wang Y, Wang D, Ding H. Role of ABCA1 in cardiovascular disease. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12061010.","journal-title":"J Pers Med"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09746-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:26:04Z","timestamp":1769156764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9746"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09746-6","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University (Approval Number: EC-024-220). Written informed consent was obtained from the guardians of all participants in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}